Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1991-06-17
1992-06-02
Ivy, C. Warren
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514253, 514269, 514274, 544310, 544316, 544319, 544333, 544405, 546168, 546176, 546255, 546256, 546257, 546261, 546262, A61K 3147, C07D40914
Patent
active
051186918
ABSTRACT:
Substituted tetrahydropyridines and derivatives thereof are described, as well as methods for the preparation and pharmaceutical composition of same, which are useful as central nervous system agents and are particularly useful as dopaminergic, antipsychotic, and antihypertensive agents as well as for treating hyperprolactinaemia-related conditions and central nervous system disorders.
REFERENCES:
patent: 4665187 (1987-05-01), Bottcher et al.
patent: 4743692 (1988-05-01), Teller et al.
patent: 4942169 (1990-07-01), Sugimoto et al.
Jaen Juan C.
Nickell David G.
Reynolds Donna M.
Smith Sarah J.
Wise Lawrence D.
Ivy C. Warren
Tinney Francis J.
Turnipseed James H.
Warner-Lambert Co.
LandOfFree
Substituted tetrahydropyridines as central nervous system agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted tetrahydropyridines as central nervous system agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted tetrahydropyridines as central nervous system agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2228649